C1q/TNF-related protein-9 inhibits cytokine-induced vascular inflammation and leukocyte adhesiveness via AMP-activated protein kinase activation in endothelial cells

Bess, 2011, Nitric oxide-induced activation of the AMP-activated protein kinase alpha2 subunit attenuates IkappaB kinase activity and inflammatory responses in endothelial cells, PLoS One, 6, e20848, 10.1371/journal.pone.0020848 Blankenberg, 2003, Adhesion molecules and atherosclerosis, Atherosclerosis, 170, 191, 10.1016/S0021-9150(03)00097-2 Bluher, 2012, Clinical relevance of adipokines, Diabetes Metab. J., 36, 317, 10.4093/dmj.2012.36.5.317 Boring, 1998, Decreased lesion formation in CCR2−/− mice reveals a role for chemokines in the initiation of atherosclerosis, Nature, 394, 894, 10.1038/29788 Bourcier, 1997, The nuclear factor kappa-B signaling pathway participates in dysregulation of vascular smooth muscle cells in vitro and in human atherosclerosis, J. Biol. Chem., 272, 15817, 10.1074/jbc.272.25.15817 Brand, 1996, Activated transcription factor nuclear factor-kappa B is present in the atherosclerotic lesion, J. Clin. Investig., 97, 1715, 10.1172/JCI118598 Brand, 1997, Role of nuclear factor-kappa B in atherogenesis, Exp. Physiol., 82, 297, 10.1113/expphysiol.1997.sp004025 Carcamo, 2002, Vitamin C suppresses TNF alpha-induced NF kappa B activation by inhibiting I kappa B alpha phosphorylation, Biochemistry, 41, 12995, 10.1021/bi0263210 Chandrasekar, 2008, Adiponectin blocks interleukin-18-mediated endothelial cell death via APPL1-dependent AMP-activated protein kinase (AMPK) activation and IKK/NF-kappaB/PTEN suppression, J. Biol. Chem., 283, 24889, 10.1074/jbc.M804236200 Choi, 2013, Clinical implications of adipocytokines and newly emerging metabolic factors with relation to insulin resistance and cardiovascular health, Front. Endocrinol. (Lausanne), 4, 97, 10.3389/fendo.2013.00097 Davis, 2006, Activation of the AMP-activated kinase by antidiabetes drug metformin stimulates nitric oxide synthesis in vivo by promoting the association of heat shock protein 90 and endothelial nitric oxide synthase, Diabetes, 55, 496, 10.2337/diabetes.55.02.06.db05-1064 Hardie, 2004, The AMP-activated protein kinase pathway–new players upstream and downstream, J. Cell Sci., 117, 5479, 10.1242/jcs.01540 Hattori, 2002, Vascular smooth muscle cell activation by glycated albumin (Amadori adducts), Hypertension, 39, 22, 10.1161/hy1201.097300 Hattori, 2006, Metformin inhibits cytokine-induced nuclear factor kappaB activation via AMP-activated protein kinase activation in vascular endothelial cells, Hypertension, 47, 1183, 10.1161/01.HYP.0000221429.94591.72 Huang, 2010, Association of adiponectin with future cardiovascular events in patients after acute myocardial infarction, J. Atheroscler. Thromb., 17, 295, 10.5551/jat.3533 Hwang, 2014, Association of serum C1q/TNF-Related Protein-9 (CTRP9) concentration with visceral adiposity and metabolic syndrome in humans, Int. J. Obes. (Lond), 38, 1207, 10.1038/ijo.2013.242 Iiyama, 1999, Patterns of vascular cell adhesion molecule-1 and intercellular adhesion molecule-1 expression in rabbit and mouse atherosclerotic lesions and at sites predisposed to lesion formation, Circ. Res., 85, 199, 10.1161/01.RES.85.2.199 Iwai, 2012, Diverse ubiquitin signaling in NF-kappaB activation, Trends Cell Biol., 22, 355, 10.1016/j.tcb.2012.04.001 Jung, 2014, Association of serum C1q/TNF-related protein-9 concentration with arterial stiffness in subjects with type 2 diabetes, J. Clin. Endocrinol. Metab., 99, E2477, 10.1210/jc.2014-2524 Kambara, 2012, CTRP9 protein protects against myocardial injury following ischemia-reperfusion through AMP-activated protein kinase (AMPK)-dependent mechanism, J. Biol. Chem., 287, 18965, 10.1074/jbc.M112.357939 Kambara, 2015, C1q/Tumor necrosis factor-related protein 9 protects against acute myocardial injury through an adiponectin receptor I-AMPK-dependent mechanism, Mol. Cell Biol., 35, 2173, 10.1128/MCB.01518-14 Kishore, 2004, C1q and tumor necrosis factor superfamily: modularity and versatility, Trends Immunol., 25, 551, 10.1016/j.it.2004.08.006 Li, 2015, CTRP9 enhances carotid plaque stability by reducing pro-inflammatory cytokines in macrophages, Biochem. Biophys. Res. Commun., 458, 890, 10.1016/j.bbrc.2015.02.054 Liang, 2015, Angiotensin-(1-7) attenuates angiotensin ii-induced ICAM-1, VCAM-1, and MCP-1 expression via the MAS receptor through suppression of P38 and NF-kappaB pathways in HUVECs, Cell Physiol. Biochem., 35, 2472, 10.1159/000374047 Libby, 2002, Inflammation and atherosclerosis, Circulation, 105, 1135, 10.1161/hc0902.104353 Min, 2005, TNF-related activation-induced cytokine enhances leukocyte adhesiveness: induction of ICAM-1 and VCAM-1 via TNF receptor-associated factor and protein kinase C-dependent NF-kappaB activation in endothelial cells, J. Immunol., 175, 531, 10.4049/jimmunol.175.1.531 Motoshima, 2004, Adiponectin suppresses proliferation and superoxide generation and enhances eNOS activity in endothelial cells treated with oxidized LDL, Biochem. Biophys. Res. Commun., 315, 264, 10.1016/j.bbrc.2004.01.049 Musi, 2002, Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes, Diabetes, 51, 2074, 10.2337/diabetes.51.7.2074 Onat, 2011, Human vascular endothelial cells: a model system for studying vascular inflammation in diabetes and atherosclerosis, Curr. Diab. Rep., 11, 193, 10.1007/s11892-011-0182-2 Ouchi, 1999, Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin, Circulation, 100, 2473, 10.1161/01.CIR.100.25.2473 Park, 2002, Phosphorylation-activity relationships of AMPK and acetyl-CoA carboxylase in muscle, J. Appl. Physiol. (1985), 92, 2475, 10.1152/japplphysiol.00071.2002 Schaffler, 2012, CTRP family: linking immunity to metabolism, Trends Endocrinol. Metab., 23, 194, 10.1016/j.tem.2011.12.003 Seldin, 2014, Metabolic function of the CTRP family of hormones, Rev. Endocr. Metab. Disord., 15, 111, 10.1007/s11154-013-9255-7 Uemura, 2013, Adipose-derived factor CTRP9 attenuates vascular smooth muscle cell proliferation and neointimal formation, FASEB J., 27, 25, 10.1096/fj.12-213744 Wong, 2009, Identification and characterization of CTRP9, a novel secreted glycoprotein, from adipose tissue that reduces serum glucose in mice and forms heterotrimers with adiponectin, FASEB J., 23, 241, 10.1096/fj.08-114991 Zheng, 2011, C1q/TNF-related proteins, a family of novel adipokines, induce vascular relaxation through the adiponectin receptor-1/AMPK/eNOS/nitric oxide signaling pathway, Arterioscler. Thromb. Vasc. Biol., 31, 2616, 10.1161/ATVBAHA.111.231050 Zou, 2008, AMP-activated protein kinase activation as a strategy for protecting vascular endothelial function, Clin. Exp. Pharmacol. Physiol., 35, 535, 10.1111/j.1440-1681.2007.04851.x Zou, 2004, Activation of the AMP-activated protein kinase by the anti-diabetic drug metformin in vivo. Role of mitochondrial reactive nitrogen species, J. Biol. Chem., 279, 43940, 10.1074/jbc.M404421200